查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496093

AI-ECG平台市场：现况分析与预测（2024-2032）

AI-ECG Platform Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于心血管疾病盛行率不断上升，预计 AI-ECG 平台市场在预测期内将以 27% 的复合年增长率强劲增长。心血管疾病（CVD）是世界上死亡和残疾的主要原因，给全球卫生系统带来了沉重负担。这种令人震惊的趋势是推动人工智慧驱动的心电图（心电图）市场成长的关键因素。CVD 盛行率的增加需要先进的诊断工具。例如，美国疾病管制与预防中心 (CDC) 报告称，心臟病是美国的首要死因，每年夺走 65 万人的生命。

依类型划分，市场分为本地和云端。AI-ECG 市场的云端细分市场由多个正在重塑心臟治疗格局的驱动因素所推动。首先，基于云端的解决方案提供的可扩展性和灵活性使医疗保健提供者能够有效地管理和储存大量心电图数据，从而使与现有电子健康记录(EHR) 系统的无缝整合变得更加容易。其次，基于云端的AI-ECG平台利用先进的机器学习演算法即时分析心电图数据，从而实现更快的诊断和治疗决策。

依最终用户划分，市场分为医院、诊所等。到2023年，医院将占据压倒性的市场占有率。由于先进技术在医疗保健领域的整合，人工智慧心电图市场的医院领域正在显着成长。AI-ECG 解决方案为医院提供诊断准确性、效率并增强患者护理。这些系统利用机器学习演算法来分析心电图数据、检测异常情况并为医疗专业人员提供即时见解。医院正在采用 AI-ECG 解决方案来简化工作流程、减少解读错误并改善病患治疗结果。这些系统能够快速解释心电图结果，使医生能够及时做出患者护理决策。此外，人工智慧演算法可以识别心臟病的微妙模式和指标，支援早期检测和介入。此外，人工智慧心电图技术有助于远端监控和远距医疗计划，使医院能够将其业务范围扩展到传统医疗环境之外。这对于监测慢性病患者或偏远地区的患者特别有用。

为了更瞭解AI-ECG平台产业的市场采用情况，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太地区其他地区）和世界其他地区。北美在市场上占据主导地位，预计这一趋势在预测期内将持续下去。近年来，由于人工智慧技术的进步和心血管疾病盛行率的增加，北美人工智慧心电图平台市场经历了显着增长。这些平台利用人工智慧演算法来分析心电图 (ECG) 数据，为医疗专业人员提供诊断、治疗和监测心臟病的宝贵见解。市场格局的特点是参与者多元化，包括成熟的医疗技术公司、新创公司和研究机构，每个人都为 AI-ECG 解决方案的创新和扩展做出了贡献。

目录

第1章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第2章 研究方法或前提条件

  • 调查过程
  • 调查方法
  • 受访者简介

第3章 市场总结

第4章 执行摘要

第5章 2022-2032年全球AI-ECG平台市场收入

第6章 市场分析：依类型

  • 本地
  • 云端

第7章 市场分析：依最终用户

  • 医院
  • 诊所
  • 其他

第8章市场分析：依地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区

第9章 AI-ECG平台市场动态

  • 市场驱动力
  • 市场课题
  • 影响分析

第10章 AI-ECG平台市场机会

第11章 AI-ECG平台市场趋势

第12章 需求侧和供给面分析

  • 需求面分析
  • 供给侧分析

第13章 价值链分析

第14章 价格分析

第15章 竞争场景

  • 波特五力分析
  • 竞争格局

第16章 公司简介

  • Cardiomatics
  • Powerful Medical
  • XOresearch
  • Viatom Technology Co.,Ltd.
  • IDOVEN
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • AliveCor, Inc.
  • anumana, Inc.
  • ACCURKARDIA.
  • Medtronic

第17章 免责声明

简介目录
Product Code: UMHE212731

The AI-ECG platform market has witnessed remarkable growth in recent years, fueled by advancements in artificial intelligence (AI) technology and the increasing demand for efficient healthcare solutions. Electrocardiography (ECG) is a fundamental diagnostic tool used to assess cardiac health, and the integration of AI into ECG platforms has revolutionized the way cardiac conditions are diagnosed and managed. This market encompasses a wide range of AI-powered solutions designed to analyze ECG data, detect abnormalities, and provide clinical insights in real-time. One of the key drivers propelling the growth of the AI-ECG platform market is the growing prevalence of cardiovascular diseases (CVDs) worldwide. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. With the burden of CVDs continuing to rise, there is a pressing need for innovative technologies that can improve the accuracy and efficiency of cardiac diagnostics.

The AI-ECG Platform Market is expected to grow at a strong CAGR of 27% during the forecast period owing to increasing prevalence of cardiovascular diseases. Cardiovascular diseases (CVDs) are the world's leading cause of death and disability, placing a significant burden on healthcare systems globally. This alarming trend is a major driver for the growth of the AI-powered ECG (electrocardiogram) market. The increasing prevalence of CVDs necessitates advanced diagnostic tools. For instance, the Centers for Disease Control and Prevention (CDC) reports that heart disease is the leading cause of death in the US, taking nearly 650,000 lives annually.

Based on the type, the market is bifurcated into on-premise and cloud. The cloud segment in the AI-ECG market is being propelled by several driving factors that are reshaping the landscape of cardiac care. Firstly, the scalability and flexibility offered by cloud-based solutions enable healthcare providers to efficiently manage and store large volumes of ECG data, facilitating seamless integration with existing electronic health records (EHR) systems. Secondly, cloud-based AI-ECG platforms leverage advanced machine learning algorithms to analyze ECG data in real-time, enabling faster diagnosis and treatment decision-making.

By end user, the market is segmented into hospitals, clinics, and others. The hospitals held dominant share of the market in 2023. The hospital segment in the AI-ECG market is experiencing significant growth due to the integration of advanced technologies in healthcare. AI-powered ECG solutions offer hospitals enhanced diagnostic accuracy, efficiency, and patient care. These systems utilize machine learning algorithms to analyze ECG data, detect abnormalities, and provide real-time insights to healthcare professionals. Hospitals are adopting AI-ECG solutions to streamline workflow, reduce interpretation errors, and improve patient outcomes. These systems enable quicker interpretation of ECG results, allowing physicians to make timely decisions for patient care. Additionally, AI algorithms can identify subtle patterns and indicators of cardiac conditions, assisting in early detection and intervention. Furthermore, AI-ECG technology facilitates remote monitoring and telemedicine initiatives, enabling hospitals to extend their reach beyond traditional healthcare settings. This is particularly beneficial for monitoring patients with chronic conditions or those in remote areas.

For a better understanding of the market adoption of the AI-ECG platform industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America held the dominant share of the market and is expected to do so even in the forecast period. The North America AI-ECG platform market has experienced remarkable growth in recent years, driven by advancements in AI technology and the increasing prevalence of cardiovascular diseases. These platforms utilize AI algorithms to analyze electrocardiogram (ECG) data, providing healthcare professionals with valuable insights for diagnosis, treatment, and monitoring of cardiac conditions. The market landscape is characterized by a diverse range of players, including established healthcare technology companies, startups, and research institutions, each contributing to the innovation and expansion of AI-ECG solutions.

Some of the major players operating in the market include Cardiomatics; Powerful Medical; XOresearch; Viatom Technology Co.,Ltd.; IDOVEN; Lepu Medical Technology(Beijing)Co.,Ltd.; AliveCor, Inc.; anumana, Inc.; ACCURKARDIA, and Medtronic.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the AI-ECG Platform Market
  • 2.2. Research Methodology of the AI-ECG Platform Market
  • 2.3. Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.GLOBAL AI-ECG PLATFORM MARKET REVENUE, 2022-2032F

6.MARKET INSIGHTS BY TYPE

  • 6.1. On-Premise
  • 6.2. Cloud

7.MARKET INSIGHTS BY END USER

  • 7.1. Hospital
  • 7.2. Clinics
  • 7.3. Others

8.MARKET INSIGHTS BY REGION

  • 8.1. North America
    • 8.1.1. United States
    • 8.1.2. Canada
    • 8.1.3. Rest of North America
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia Pacific
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia Pacific
  • 8.4. Rest of World

9.AI-ECG PLATFORM MARKET DYNAMICS

  • 9.1. Market Drivers
  • 9.2. Market Challenges
  • 9.3. Impact Analysis

10.AI-ECG PLATFORM MARKET OPPORTUNITIES

11.AI-ECG PLATFORM MARKET TRENDS

12.DEMAND AND SUPPLY-SIDE ANALYSIS

  • 12.1. Demand Side Analysis
  • 12.2. Supply Side Analysis

13.VALUE CHAIN ANALYSIS

14.PRICING ANALYSIS

15.COMPETITIVE SCENARIO

  • 15.1. Porter's Five Forces Analysis
  • 15.2. Competitive Landscape

16.COMPANY PROFILED

  • 16.1. Cardiomatics
  • 16.2. Powerful Medical
  • 16.3. XOresearch
  • 16.4. Viatom Technology Co.,Ltd.
  • 16.5. IDOVEN
  • 16.6. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 16.7. AliveCor, Inc.
  • 16.8. anumana, Inc.
  • 16.9. ACCURKARDIA.
  • 16.10. Medtronic

17.DISCLAIMER